Myriad Genetics Inc
MYGN- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000899923
No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Myriad Genetics Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 188 | 1 | 186 | −1 |
| Shares | 81.2M | 1.10M | 82.7M | +2.63M (+3.3%) |
| Value | $1.88B | $25.4M | $1.33B | −$527.3M (−28.4%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Myriad Genetics Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management Holding SA | 1,218,246 | $19.5M | 0.02% |
| HRT Financial LP | 70,472 | $1.13M | 0.01% |
| Captrust Financial Advisors | 26,783 | $429.6K | 0.00% |
| Point72 Middle East FZE | 25,120 | $402.9K | 0.02% |
| Allianz Asset Management GmbH | 25,100 | $402.6K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 19,548 | $313.6K | 0.03% |
| Monticello Wealth Management, LLC | 14,617 | $234.5K | 0.02% |
| Vident Advisory, LLC | 12,081 | $193.8K | 0.01% |
| GTS Securities LLC | 11,779 | $188.9K | 0.00% |
| Aquatic Capital Management LLC | 5,200 | $83.0K | 0.00% |
| Walleye Capital LLC | 321 | $5.15K | 0.00% |
| Allworth Financial LP | 53 | $851 | 0.00% |
| Northwestern Mutual Wealth Management Co | 42 | $674 | 0.00% |
| Jones Financial Companies LLLP | 41 | $658 | 0.00% |
| JNBA Financial Advisors | 10 | $161 | 0.00% |
| Steward Financial Group LLC | 10 | $0 | 0.00% |
Sold out (17)
Institutions that held Myriad Genetics Inc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Polar Asset Management Partners Inc. | 166,057 | $3.85M |
| State of New Jersey Common Pension Fund D | 108,605 | $2.52M |
| Caption Management, LLC | 85,017 | $1.97M |
| Connectus Wealth, LLC | 83,754 | $1.94M |
| Ergoteles LLC | 28,710 | $665.5K |
| Trexquant Investment LP | 27,604 | $639.9K |
| XTX Topco Ltd | 9,825 | $227.7K |
| Teza Capital Management LLC | 9,766 | $226.4K |
| CIBC Asset Management Inc | 8,993 | $208.5K |
| Graham Capital Management, L.P. | 8,815 | $204.3K |
| Russell Investments Group, Ltd. | 668 | $15.5K |
| Massmutual Trust Co FSB | 267 | $6.19K |
| Bokf, NA | 144 | $3.34K |
| Ridgewood Investments LLC | 101 | $2.33K |
| Bessemer Group Inc | 68 | $2.00K |
| Lindbrook Capital, LLC | 17 | $394 |
| Disciplined Investments, LLC | 11 | $255 |
Not filed for Q3 2023 yet (1)
Institutions that held Myriad Genetics Inc at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 1,095,566 | $25.4M |